More Access and Evidence Articles

Access and Evidence

Transformers

Hugh Gosling, (Oct 26, 2017)

An expert powerhouse involved in key strategic decisions right across the lifecycle, Market Access has come a long way in a short time
Access and Evidence

A Change Is Coming

Danielle Barron, (Oct 9, 2017)

Health technology assessment is building up steam in the US – and pharma needs to prepare for it
Access and Evidence

Pragmatic Trials: The Real-World Data Revolution

Adam Chapman, (Sep 27, 2017)

Insights derived from real-world data are changing every facet of pharma but its impact on clinical trials may prove to be a crowning achievement
Access and Evidence

Indication-Based Pricing: A Utopian Ideal?

Adam Chapman, (Sep 11, 2017)

The potential benefits of moving to a variable pricing model based on indication are manifold, but is the US healthcare system ready?
Access and Evidence

Thinking Outside The Box

Adam Chapman, (Sep 5, 2017)

In digital, it’s all about personalization. Isn’t it time pharma caught up with other industries?
Access and Evidence

Finding Common Ground: Australian Government Seeks Closer Ties With Pharma

Adam Chapman, (Aug 30, 2017)

The Australian government asks for pharma’s help to ensure patients gain fast access to new medicines
Access and Evidence

Big Data, Huge Opportunity

Nancy Bergquist, (Aug 22, 2017)

Insights derived from big data are transforming the healthcare landscape, offering marketers a high-definition view of the patient and customer
Access and Evidence

When Real-World Evidence met Patient-Centricity

Hugh Gosling, (Jul 28, 2017)

If real-world evidence and patient-centricity teamed up could they cure all of pharma’s ills?
Access and Evidence

Booming Biosimilars

Danielle Barron, (Jul 11, 2017)

Regulatory changes are paving the way for speedier access to biosimilars in the US, while gain-share agreements are driving strong adoption rates in Europe.
Access and Evidence

US Pharma Peers Into The Unknown

Lucy Fulford, (Jul 10, 2017)

Despite many bumps in the road and a lack of clear direction, the US healthcare ecosystem always finds a way to deliver its goal – improving the health and well-being of every American

Pages